Exotic Biosolutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.90%
- Profit Growth -24.95%
- Ebitda -49.16%
- Net Worth 9.49%
- Total Assets 14.33%
About Exotic Biosolutions
Exotic Biosolutions Private Limited (EBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 September 2007 and has a history of 17 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinayak Kamath and Sudhanshu Chousalkar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01400MH2007PTC173812
- Company No.
173812
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Exotic Biosolutions Private Limited offer?
Exotic Biosolutions Private Limited offers a wide range of products and services, including Farming and Pet Animals, Poultry Farm Chicks, Door & Window, Hinges & Fittings, Steel Hinges.
Who are the key members and board of directors at Exotic Biosolutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinayak Kamath  | Director | 05-Sep-2007 | Current |
| Sudhanshu Chousalkar | Director | 05-Sep-2007 | Current |
Financial Performance of Exotic Biosolutions.
Exotic Biosolutions Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.9% decrease. The company also saw a substantial fall in profitability, with a 24.95% decrease in profit. The company's net worth moved up by a moderate rise of 9.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exotic Biosolutions?
In 2020, Exotic Biosolutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exotic Biosolutions?
Exotic Biosolutions has a workforce of 8 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exotic Biosolutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exotic Biosolutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.